Exploring GLP-1 Receptor Agonists: Beyond Cardiometabolic Effects
In recent years, the therapeutic landscape of metabolic and cardiovascular diseases has been revolutionized by glucagon-like peptide-1 receptor agonists (GLP-1 ...
In recent years, the therapeutic landscape of metabolic and cardiovascular diseases has been revolutionized by glucagon-like peptide-1 receptor agonists (GLP-1 ...
A newly published study focusing on Medicare beneficiaries aged 65 and older with type 2 diabetes has identified a noteworthy ...
A recent cohort study published in JAMA Ophthalmology has unveiled a potentially alarming association between the use of glucagon-like peptide-1 ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine